v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:      
Net (loss) income $ (397,907) $ (356,734) $ 4,231,206
Adjustments to reconcile net (loss) income to net cash used in operating activities:      
Share-based compensation 346,165 289,029 199,627
Change in fair value of investments (105,046) (55,186) 47,973
Change in fair value of debt and liability instruments 47,704 (113,078) 78,943
Gain on sale of subsidiary interests 0 (376,506) 0
Gain on deconsolidation of subsidiaries (11,027) (3,108) (32,772)
Gain on sale of Telavant net assets 0 (110,387) (5,348,410)
Impairment loss on operating lease right-of-use assets 15,594 0 0
Accretion of discount and amortization of premium on available-for-sale marketable securities, net (22,992) 0 0
Accretion of discount and amortization of premium on held-to-maturity marketable securities, net (13,520) (69,959) 0
Realized gain from sales of marketable securities (976) 0 0
Loss on extinguishment of debt 0 8,848 0
Depreciation and amortization 3,348 14,071 22,036
Non-cash lease expense 8,276 6,843 6,845
Other 1,828 3,762 10,249
Changes in assets and liabilities, net of effects from acquisition and divestiture:      
Other current assets 11,459 (25,070) (81,478)
Other assets (7,416) (8,758) 16,488
Litigation settlement receivable (770,235) 0 0
Accounts payable 3,418 (18,168) 22,684
Accrued expenses 59,326 (10,070) 40,150
Operating lease liabilities (2,385) (5,700) (8,326)
Accrued interest 0 0 21,977
Income tax payable 85,045 (10,053) 9,927
Other liabilities (1,008) 773 (2,387)
Net cash used in operating activities (750,349) (839,451) (765,268)
Marketable securities, available-for-sale      
Purchases (4,795,855) 0 0
Proceeds from maturities 1,122,300 0 0
Proceeds from sales 821,367 0 0
Marketable securities, held-to-maturity      
Purchases 0 (4,061,521) 0
Proceeds from maturities 2,185,000 1,960,000 0
Proceeds from sale of Telavant net assets, net 0 110,387 5,233,396
Proceeds from sale of subsidiary interests 0 260,586 47,500
Cash decrease upon deconsolidation of subsidiaries (4,418) (31,223) (84,483)
Purchase of property and equipment (8,209) (4,599) (1,382)
Other (2,518) 79 8,592
Net cash (used in) provided by investing activities (682,333) (1,766,291) 5,203,623
Cash flows from financing activities:      
Proceeds from issuance of the Company’s common shares, net of issuance costs paid 0 0 199,822
Proceeds from issuance of subsidiary common shares, net of issuance costs paid 193,605 112,782 238,733
Repayment of debt by subsidiary 0 (51,979) (29,158)
Contribution from minority interest holder to subsidiary 39,250 0 0
Proceeds from exercise of the Company’s and subsidiary stock options 268,350 49,597 54,314
Taxes paid related to net settlement of equity awards (48,621) (37,216) (37,715)
Proceeds from issuance of the Company’s common shares under employee stock purchase plan 1,155 1,028 951
Payments on principal portion of finance lease obligations 0 (774) (1,547)
Payment of subsidiary dividend 0 0 (6,000)
Proceeds from exercise of the Company’s warrants 0 0 5
Payment for redemptions of the Company’s warrants 0 0 (41)
Net cash provided by (used in) financing activities 134,236 (1,219,794) 419,364
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,767 747 616
Net change in cash, cash equivalents and restricted cash (1,294,679) (3,824,789) 4,858,335
Cash, cash equivalents and restricted cash at beginning of period 2,725,661 6,550,450 1,692,115
Cash, cash equivalents and restricted cash at end of period 1,430,982 2,725,661 6,550,450
Non-cash investing and financing activities:      
Cashless exercise of the Company’s warrants 0 0 83,258
Issuance of subsidiary shares in connection with debt renegotiation 0 11,647 0
Operating lease right-of-use assets obtained and exchanged for operating lease liabilities 9,605 51,364 1,790
Reclassification of earn-out shares liability to additional paid-in capital upon vesting 57,685 0 0
Taxes payable related to net settlement of equity awards 31,114 0 0
Other 3,352 59 441
Supplemental disclosure of cash paid:      
Interest paid 0 5,963 10,268
Parent Company      
Cash flows from financing activities:      
Repurchase of the Company’s common shares (318,103) (1,293,232) 0
Subsidiaries      
Cash flows from financing activities:      
Repurchase of the Company’s common shares $ (1,400) $ 0 $ 0